Schedule 13G ownership disclosure
Immunome Inc
Common Stock, $0.0001 Par Value · CUSIP: 45257U108
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Redmile Group, LLC
Shares: 5,361,187.00 · Class: 6.2%
- Jeremy C. Green
Shares: 5,361,187.00 · Class: 6.2%
- Redmile Biopharma Investments III, L.P.
Shares: 3,879,415.00 · Class: 4.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-049702
- Form type
- SCHEDULE 13G/A
- Filer
- Immunome Inc.
- CIK
- CIK 1472012
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership